Reuters logo
BRIEF-Medtronic announces voluntary recall of diabetes infusion sets
September 11, 2017 / 11:37 AM / 3 months ago

BRIEF-Medtronic announces voluntary recall of diabetes infusion sets

Sept 11 (Reuters) - Medtronic Plc:

* Medtronic announces voluntary recall of diabetes infusion sets

* Medtronic-‍determined a component, vent membrane, in recalled infusion sets may be susceptible to being blocked by fluid during process of priming/fill-tubing​

* Medtronic PLC - ‍recall is related to a certain discontinued component in infusion sets and does not include insulin pumps or glucose sensors​

* Medtronic - started to inform patients worldwide of voluntary recall of specific lots of infusion sets used with all models of medtronic insulin pumps​

* Medtronic - infusion sets available since April 2017 include design update of vent membrane which co believes reduces risk of insulin over-delivery

* Medtronic plc - ‍voluntary recall of infusion sets is not expected to impact diabetes group revenue growth in q2 or full fiscal year​

* Medtronic plc - ‍ majority of cost due to recall of infusion sets is expected to be incurred in q2

* Medtronic plc - cost of recall is not expected to impact earnings per share guidance in q2 or full fiscal year Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below